Paul K. Audhya - Net Worth and Insider Trading
Paul K. Audhya Net Worth
The estimated net worth of Paul K. Audhya is at least $978,851 dollars as of 2024-11-29. Paul K. Audhya is the CHIEF MEDICAL OFFICER of KalVista Pharmaceuticals Inc and owns about 97,012 shares of KalVista Pharmaceuticals Inc (KALV) stock worth over $978,851. Details can be seen in Paul K. Audhya's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul K. Audhya has not made any transactions after 2024-11-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Paul K. Audhya
Paul K. Audhya Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul K. Audhya owns 1 companies in total, including KalVista Pharmaceuticals Inc (KALV) .
Click here to see the complete history of Paul K. Audhya’s form 4 insider trades.
Insider Ownership Summary of Paul K. Audhya
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KALV | KalVista Pharmaceuticals Inc | 2024-11-18 | Chief Medical Officer |
Paul K. Audhya Latest Holdings Summary
Paul K. Audhya currently owns a total of 1 stock. Paul K. Audhya owns 97,012 shares of KalVista Pharmaceuticals Inc (KALV) as of November 26, 2024, with a value of $978,851.
Latest Holdings of Paul K. Audhya
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KALV | KalVista Pharmaceuticals Inc | 2024-11-26 | 97,012 | 10.09 | 978,851 |
Holding Weightings of Paul K. Audhya
Paul K. Audhya Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul K. Audhya has made a total of 12 transactions in KalVista Pharmaceuticals Inc (KALV) over the past 5 years, including 0 buys and 12 sells. The most-recent trade in KalVista Pharmaceuticals Inc is the sale of 2,187 shares on November 26, 2024, which brought Paul K. Audhya around $21,586.
Insider Trading History of Paul K. Audhya
- 1
Paul K. Audhya Trading Performance
Paul K. Audhya Ownership Network
Paul K. Audhya Owned Company Details
What does KalVista Pharmaceuticals Inc do?
Who are the key executives at KalVista Pharmaceuticals Inc?
Paul K. Audhya is the Chief Medical Officer of KalVista Pharmaceuticals Inc. Other key executives at KalVista Pharmaceuticals Inc include Chief Development Officer Christopher Yea , CFO and Secretary Benjamin L Palleiko , and Chief Scientific Officer Edward P. Feener .
KalVista Pharmaceuticals Inc (KALV) Insider Trades Summary
Over the past 18 months, Paul K. Audhya made 8 insider transaction in KalVista Pharmaceuticals Inc (KALV) with a net sale of 63,847. Other recent insider transactions involving KalVista Pharmaceuticals Inc (KALV) include a net purchase of 1,251,017 shares made by Venrock Healthcare Capital Partners Iii, L.p. , a net sale of 155,123 shares made by Benjamin L Palleiko , and a net sale of 95,977 shares made by Christopher Yea .
In summary, during the past 3 months, insiders sold 41,171 shares of KalVista Pharmaceuticals Inc (KALV) in total and bought 0 shares, with a net sale of 41,171 shares. During the past 18 months, 600,355 shares of KalVista Pharmaceuticals Inc (KALV) were sold and 1,251,017 shares were bought by its insiders, resulting in a net purchase of 650,662 shares.
KalVista Pharmaceuticals Inc (KALV)'s detailed insider trading history can be found in Insider Trading Tracker table.
KalVista Pharmaceuticals Inc Insider Transactions
Paul K. Audhya Mailing Address
Above is the net worth, insider trading, and ownership report for Paul K. Audhya. You might contact Paul K. Audhya via mailing address: C/o Kalvista Pharmaceuticals, Inc., 55 Cambridge Parkway, Suite 901e, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
